{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T12:36:08Z","timestamp":1776688568156,"version":"3.51.2"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T00:00:00Z","timestamp":1646179200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T00:00:00Z","timestamp":1646179200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Of the many types of laser cyclophotocoagulation procedures, micropulse cyclophotocoagulation diode is praised as a noninvasive, safe, and effective procedure with few complications. In this case report, we describe a rare complication that, to the best of our knowledge, has not been previously reported.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case report<\/jats:title>\n                <jats:p>We report on the case of a 66-year-old African man with a history of end-stage primary open-angle glaucoma. One week after undergoing micropulse cyclophotocoagulation diode therapy in both eyes, he developed severe intermediary inflammation in one eye, associated with decreased visual acuity. The intraocular pressure had significantly decreased after the procedure and was well controlled with intraocular-pressure-lowering medications. Slit lamp examination revealed a moderate anterior chamber inflammation, anterior vitritis, and a large inflammatory membrane attached to the posterior surface of the intraocular implant. A vitrectomy was finally performed in the left eye because of the persistent intermediary inflammation despite the use of high doses of topical and subconjunctival corticosteroids.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Intermediary uveitis is a rare complication after micropulse cyclophotocoagulation diode therapy. To the best of our knowledge, there have been no reports of vitritis after a noncomplicated micropulse cyclophotocoagulation diode in primary open-angle glaucoma.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-022-03307-9","type":"journal-article","created":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T00:02:22Z","timestamp":1646179342000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Intermediary inflammatory reaction after micropulse cyclophotocoagulation diode therapy: a case report"],"prefix":"10.1186","volume":"16","author":[{"given":"Ga\u00ebtane","family":"Ghion","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayeh","family":"Pourjavan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,2]]},"reference":[{"issue":"3","key":"3307_CR1","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1442-9071.2010.02238.x","volume":"38","author":"AM Tan","year":"2010","unstructured":"Tan AM, Chockalingam M, Aquino MC, Lim ZI, See JL, Chew PT. Micropulse transscleral diode laser cyclophotocoagulation in the treatment of refractory glaucoma. Clin Exp Ophthalmol. 2010;38(3):266\u201372. https:\/\/doi.org\/10.1111\/j.1442-9071.2010.02238.x.","journal-title":"Clin Exp Ophthalmol"},{"key":"3307_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoc.2020.100659","author":"AJ Prager","year":"2020","unstructured":"Prager AJ, Anchala AR. Suprachoroidal hemorrhage after micropulse cyclophotocoagulation diode therapy. Am J Ophthalmol Case Rep. 2020. https:\/\/doi.org\/10.1016\/j.ajoc.2020.100659.","journal-title":"Am J Ophthalmol Case Rep."},{"key":"3307_CR3","unstructured":"IRIDEX (internet). (updated on:-; consulted on 10\/11\/2020), to consult on: https:\/\/iridex.com\/MicroPulse.aspx."},{"issue":"3","key":"3307_CR4","doi-asserted-by":"publisher","first-page":"793","DOI":"10.3390\/nu12030793","volume":"12","author":"S Gandolfi","year":"2020","unstructured":"Gandolfi S, Marchini G, Caporossi A, et\u00a0al. Cytidine 5\u2019-diphosphocholine (Citicoline): evidence for a neuroprotective role in glaucoma. Nutrients. 2020;12(3):793. https:\/\/doi.org\/10.3390\/nu12030793.","journal-title":"Nutrients"},{"issue":"2","key":"3307_CR5","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1097\/00061198-200404000-00008","volume":"13","author":"A Neelakantan","year":"2004","unstructured":"Neelakantan A, Vaishnav HD, Iyer SA, Sherwood MB. Is addition of a third or fourth antiglaucoma medication effective? J Glaucoma. 2004;13(2):130\u20136. https:\/\/doi.org\/10.1097\/00061198-200404000-00008 (PMID: 15097258).","journal-title":"J Glaucoma"},{"issue":"10","key":"3307_CR6","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1097\/IJG.0000000000000748","volume":"26","author":"F Aptel","year":"2017","unstructured":"Aptel F, Bron AM, Lachkar Y, Schweitzer C. Change in visual field progression following treatment escalation in primary open-angle glaucoma. J Glaucoma. 2017;26(10):875\u201380. https:\/\/doi.org\/10.1097\/IJG.0000000000000748 (PMID: 28834827).","journal-title":"J Glaucoma"},{"key":"3307_CR7","doi-asserted-by":"crossref","unstructured":"Bernardi E, T\u00f6teberg-Harms M. Micro-pulse transscleral laser therapy and \u2018Topical-plus\u2019 anaesthesia: ideal for glaucoma management during COVID-19. touchREVIEWS Ophthalmol. 2021;15(2):","DOI":"10.17925\/USOR.2021.15.2.50"},{"issue":"1","key":"3307_CR8","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/ceo.12360","volume":"43","author":"MC Aquino","year":"2015","unstructured":"Aquino MC, Barton K, Tan AM, et\u00a0al. Micropulse versus continuous wave transscleral diode cyclophotocoagulation in refractory glaucoma: a randomized exploratory study. Clin Exp Ophthalmol. 2015;43(1):40\u20136. https:\/\/doi.org\/10.1111\/ceo.12360.","journal-title":"Clin Exp Ophthalmol"},{"key":"3307_CR9","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1097\/IJG.0000000000000715","volume":"26","author":"ME Emanuel","year":"2017","unstructured":"Emanuel ME, Grover DS, Fellman RL, et\u00a0al. Micropulse cyclophotocoagulation: initial results in refractory glaucoma. J Glaucoma. 2017;26:726\u20139.","journal-title":"J Glaucoma"},{"issue":"10","key":"3307_CR10","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1097\/IJG.0000000000001023","volume":"27","author":"A Yelenskiy","year":"2018","unstructured":"Yelenskiy A, Gillette TB, Arosemena A, et\u00a0al. Patient outcomes following micropulse transscleral cyclophotocoagulation: intermediate-term results. J Glaucoma. 2018;27(10):920\u20135. https:\/\/doi.org\/10.1097\/IJG.0000000000001023.","journal-title":"J Glaucoma"},{"issue":"6","key":"3307_CR11","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1097\/IJG.0000000000001508","volume":"29","author":"S Dhanireddy","year":"2020","unstructured":"Dhanireddy S, Yin HY, Dosakayala N, et\u00a0al. Severe inflammation and hyphema after micropulse diode transscleral cyclophotocoagulation. J Glaucoma. 2020;29(6):e50\u20132. https:\/\/doi.org\/10.1097\/IJG.0000000000001508.","journal-title":"J Glaucoma"},{"issue":"10","key":"3307_CR12","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1097\/IJG.0000000000001053","volume":"27","author":"AM Abdelrahman","year":"2018","unstructured":"Abdelrahman AM, El Sayed YM. Micropulse versus continuous wave transscleral cyclophotocoagulation in refractory pediatric glaucoma. J Glaucoma. 2018;27(10):900\u20135. https:\/\/doi.org\/10.1097\/IJG.0000000000001053.","journal-title":"J Glaucoma"},{"issue":"3","key":"3307_CR13","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/IJG.0000000000001174","volume":"28","author":"K Zaarour","year":"2019","unstructured":"Zaarour K, Abdelmassih Y, Arej N, Cherfan G, Tomey KF, Khoueir Z. Outcomes of micropulse transscleral cyclophotocoagulation in uncontrolled glaucoma patients. J Glaucoma. 2019;28(3):270\u20135. https:\/\/doi.org\/10.1097\/IJG.0000000000001174.","journal-title":"J Glaucoma"},{"issue":"9","key":"3307_CR14","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1111\/ceo.13328","volume":"46","author":"MM Abdull","year":"2018","unstructured":"Abdull MM, Broadway DC, Evans J, Kyari F, Muazu F, Gilbert C. Safety and effectiveness of primary transscleral diode laser cyclophotoablation for glaucoma in Nigeria. Clin Exp Ophthalmol. 2018;46(9):1041\u20137. https:\/\/doi.org\/10.1111\/ceo.13328.","journal-title":"Clin Exp Ophthalmol"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-022-03307-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-022-03307-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-022-03307-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T00:02:25Z","timestamp":1646179345000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-022-03307-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,2]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3307"],"URL":"https:\/\/doi.org\/10.1186\/s13256-022-03307-9","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,2]]},"assertion":[{"value":"22 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"89"}}